Evaluate gives you the understanding and time you need to drive better decisions.
Our clients include the Top 25 global pharma companies, as well as small to mid-sized pharma and biotechs. Evaluate is relied upon by their commercial teams from Business Development & Licensing to Corporate Strategy & Planning, Competitive Intelligence, and Market Analytics.
With solutions suitable for asset screening, market analysis, competitive intelligence and portfolio strategy, EvaluatePharma reduces the cost, time and risk associated with making strategic decisions.
“ Evaluate's consensus forecasts are the standard at Novartis, and have been for many years, per a mandate from senior management ”
“ Evaluate is easy to use and contains information that helps Zentiva select drugs for future development, particularly the Evaluate Consensus Forecasts ”